866-997-4948(US-Canada Toll Free)

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Portugal

Published By :

GlobalData

Published Date : Jul 2018

Category :

Pharmaceutical

No. of Pages : 127 Pages

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Portugal

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Portugal". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Portugal. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Portugal. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.

Portugals efforts to reform its drug pricing policy led to significant reductions in pharmaceutical spending, thereby, resulting in a declining trend in the pharmaceutical market. In 2016, pharmaceutical sales decreased to $2.80 billion from $4.29 billion in 2010. The market is forecast to reach $1.83 billion in 2022, at a negative CAGR of 7%. In 2010, the medical device market in Portugal was worth $1.18 billion, which increased to $1.48 billion in 2017. The main segments were cardiovascular devices, in vitro diagnostics, ophthalmic devices, hospital supplies and orthopedic devices.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Portugal, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Merck, Bial, Pfizer, Astrazeneca and Novartis) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Roche Diagnostics, DePuy Synthes, Alcon and Medbone)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Portugal
- Porters five forces analysis for pharmaceutical and medical devices market of Portugal
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Portuguese healthcare market.

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Portuguese healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Portuguese healthcare market.
Table of Contents
Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porters Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix

List of Tables
Table 1: Pharmaceutical Market, Number of wholesalers, Portugal, 2016 19
Table 2: Pharmaceutical Market, Portugal, Self Medication Product Category Sales ($m), 2015 20
Table 3: Pharmaceutical Market, Portugal, Major therapeutic groups based on drug sales ($m), 2016 21
Table 4: Medical Device Market, Portugal, Revenue by Segment ($m) and share (%), 2017 41
Table 5: Cardiovascular Devices Market, Portugal, Revenue ($m) and Market Share (%) of Major Companies, 2017 42
Table 6: IVD Devices Market, Portugal, Revenue ($m) and Market Share (%) of Major Companies, 2017 43
Table 7: Ophthalmic Devices Market, Portugal, Revenue ($m) and Market Share (%) of Major Companies, 2015 44
Table 8: Hospital Supplies Market, Portugal, Revenue ($m) and Market Share (%) of Major Companies, 2014 45
Table 9: Orthopedic Devices Market, Portugal, Revenue ($m) and Market Share (%) of Major Companies, 2017 46
Table 10: Merger & Acquisition Deals, Medical Device Market, Portugal, 2017-2018 70
Table 11: Private Equity, Deals, Medical Device Market, Portugal, 2017-2018 70
Table 12: Drug Reimbursement , Portugal, 2017 76
Table 13: NHS Expenditures on Medicines ($m) , Portugal, 2018 76
Table 14: Patent Fees, Portugal, 2018 92
Table 15: Trademark Fees, Portugal, 2018 95
Table 16: Clinical Trial Process Fees, Portugal, 2018 96
Table 17: Trade Fairs, Portugal 110

List of Figures
Figure 1: Pharmaceutical Market, Portugal, Revenue ($bn), 2010-2017 8
Figure 2: Medical Device Market, Portugal, Revenue ($bn), 2010-2017 8
Figure 3: Country Profile, Portugal, 2018 14
Figure 4: Pharmaceutical Market, Portugal, Revenue ($bn), 2010-2017 16
Figure 5: Pharmaceutical Market, Portugal, Revenue Forecast ($bn), 2018-2022 16
Figure 6: Pharmaceutical Exports ($bn), Portugal, 2010-2017 17
Figure 7: Top Export Partners, Portugal, 2017 17
Figure 8: Pharmaceutical Imports ($bn), Portugal, 2010-2017 18
Figure 9: Top Import Partners, Portugal, 2017 18
Figure 10: Distribution Channels, Portugal 19
Figure 11: Pharmaceutical Market, Portugal, Major therapeutic groups based on drug sales ($m), 2016 21
Figure 12: Pharmaceutical Market, Portugal, Major Players 23
Figure 13: Medical Device Market, Portugal, Revenue ($bn), 2010-2017 40
Figure 14: Medical Device Market, Portugal, Revenue Forecast ($bn), 2018-2022 40
Figure 15: Medical Device Market, Portugal, Revenue by Segment ($m), 2017 41
Figure 16: Cardiovascular Devices Market, Portugal, Revenue ($m), 2010-2017 42
Figure 17: Cardiovascular Devices Market, Portugal , Market Share of Major Players (%), 2017 42
Figure 18: IVD Devices Market, Portugal, Revenue ($m), 2010-2017 43
Figure 19: IVD Devices Market, Portugal, Market Share of Major Players (%), 2017 43
Figure 20: Ophthalmic Devices Market, Portugal, Revenue ($m), 2010-2017 44
Figure 21: Ophthalmic Devices Market, Portugal, Market Share of Major Players (%), 2015 44
Figure 22: Hospital Supplies Market, Portugal, Revenue ($m), 2010-2017 45
Figure 23: Hospital Supplies Market, Portugal, Market Share of Major Players (%), 2014 45
Figure 24: Orthopedic Devices Market, Portugal, Revenue ($m), 2010-2017 46
Figure 25: Orthopedic Devices Market, Portugal, Market Share of Major Companies (%), 2017 46
Figure 26: Diagnostic Market, Portugal, Revenue ($bn), 2010-2017 47
Figure 27: Diagnostic Market, Portugal, Revenue ($bn), 2018-2022 47
Figure 28: Medical Device Market, Portugal, Revenue ($bn) of Major Companies, 2016 49
Figure 29: Deal Value and Deal Count, Pharmaceutical Market, Portugal, 2017-2018 68
Figure 30: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Portugal, 2017-2018 68
Figure 31:Deal Value and Deal Count Sub-types, Pharmaceutical Market, Portugal, 2017-2018 68
Figure 32: Top Therapy Area by Deal Value ($m), Pharmaceutical Market, Portugal, 2017-2018 69
Figure 33: Top Five Therapy Area by Deal Number (M&A deals), Pharmaceutical Market,Portugal, 2017-2018 69
Figure 34: Venture Financing Deals by Therapy Area, Pharmaceutical Market, Portugal, 2017-2018 69
Figure 35: Overview of Healthcare System, Portugal, 2017 75
Figure 36: Drug Reimbursement Process , Portugal, 2017 77
Figure 37: Out-of-Pocket Expenditure (% of total expenditure on health), Portugal, 2010-2017 79
Figure 38: Change in Price Trend in Healthcare Sector (%), Portugal , 2010-2017 79
Figure 39: INFARMED, Organizational structure, Portugal, 2018 81
Figure 40: National Procedure for Market Authorization, Portugal, 2018 82
Figure 41: Centralized Procedure, Portugal, 2018 83
Figure 42: Decentralized Procedure, Portugal, 2018 84
Figure 43: Mutual Recognition Procedure, Portugal, 2018 85
Figure 44: Conformity Assessment of Class I Medical Devices, EU, 2018 87
Figure 45: Conformity Assessment of Class IIa Medical Devices, EU, 2018 88
Figure 46: Conformity Assessment of Class IIb Medical Devices, EU, 2018 89
Figure 47: Conformity Assessment of Class III Medical Devices, EU, 2018 90
Figure 48: Documents required for Manufacturing, Portugal, 2018 91
Figure 49: Patent Approval Process, Portugal, 2018 92
Figure 50: European Patent Approval Process, EU, 2018 93
Figure 51: Unitary Patent Approval Process, EU, 2017 94
Figure 52: Trademark Approval Process, Portugal, 2018 95
Figure 53: Clinical Trial Regulation Process, Portugal, 2018 96
Figure 54: Labelling and Packaging Regulations, Portugal, 2018 99
Figure 55: Hospitals (number), Portugal, 2010-2017 102
Figure 56: Hospital Bed by Type of Care (number), Portugal, 2010-2017 102
Figure 57: Diagnostic Equipment (number), Portugal, 2010-2017 102
Figure 58: Hospital Beds (per 1,000 population), Portugal, 2010 - 2017 103
Figure 59: Life Expectancy (years), Portugal, 2010-2017 103
Figure 60: Immunization Rate (%), Portugal, 2010-2017 103
Figure 61: Major Causes of Mortality, No. of deaths (000), Portugal, 2012 104
Figure 62: Major Causes of Male Mortality, No. of deaths (000), Portugal, 2015 104
Figure 63: Major Causes of Female Mortality, No. of deaths (000), Portugal, 2015 104
Figure 64: Disability-Adjusted Life Years by Major Disease (000), Portugal, 2015 104
Figure 65: Physicians (per 1,000 population), Portugal, 2010-2017 105
Figure 66: Nurses (per 1,000 population), Portugal, 2010-2017 105
Figure 67: Dentists, (per 1,000 population), Portugal, 2010-2017 105
Figure 68: Pharmacists, (per 1,000 population), Portugal, 2010-2017 105
Figure 69: PM2.5 (g per m3), Portugal, 2010-2017 106
Figure 70: CO2 Emissions (k tons), Portugal, 2010-2017 106
Figure 71: Healthcare Expenditure (% of GDP), Portugal, 2010-2017 107
Figure 72: Public-Private Share (%), Portugal, 2010-2017 107
Figure 73: Major Components of Healthcare Spending (%), Portugal, 2015 108
Figure 74: Trade Associations, Portugal 109
Figure 75: Opportunities and Challenges, Portugal 112

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *